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A B S T R A C T
Background
Overviews are a new approach to summarising evidence and synthesising results from related systematic reviews.
Objectives
To conduct an overview of Cochrane systematic reviews to provide a contemporary review of the evidence for delivery of cardiac
rehabilitation, to identify opportunities for merging or splitting existing Cochrane reviews, and to identify current evidence gaps to
inform new cardiac rehabilitation systematic review titles.
Methods
We searched The Cochrane Database of Systematic Reviews (2014, Issue 10) to identify systematic reviews that addressed the objectives
of this overview.We assessed the quality of included reviews using the Revised Assessment ofMultiple Systematic Reviews (R-AMSTAR)
measurement tool and the quality of the evidence for reported outcomes using theGRADE framework.The focus of the data presentation
was descriptive with detailed tabular presentations of review level and trial level characteristics and results.
Main results
We found six Cochrane systematic reviews and judged them to be of high methodological quality. They included 148 randomised
controlled trials (RCTs) in 98,093 participants. Compared with usual care alone, the addition of exercise-based cardiac rehabilitation
in low-risk people after myocardial infarction or percutaneous coronary intervention or with heart failure appeared to have no impact
on mortality, but did reduce hospital admissions and improved health-related quality of life. Psychological- and education-based
interventions alone appeared to have little or no impact on mortality or morbidity but may have improved health-related quality of life.
Home- and centre-based programmes were equally effective in improving quality of life outcomes at similar healthcare costs. Selected
interventions can increase the uptake of cardiac rehabilitation programmes whilst there is currently only weak evidence to support
interventions that improve adherence to cardiac rehabilitation programmes. The quality of the primary RCTs in the included systematic
reviews was variable, and limitations in the methodological quality of the RCTs led to downgrading of the quality of the evidence,
which varied widely by review and by outcome.
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Authors’ conclusions
Exercise-based cardiac rehabilitation is an effective and safe therapy to be used in the management of clinically stable people following
myocardial infarction or percutaneous coronary intervention or who have heart failure. Future RCTs of cardiac rehabilitation need
to improve their reporting methods and reflect the real world practice better including the recruitment of higher risk people and
consideration of contemporary models of cardiac rehabilitation delivery, and identify effective interventions for enhancing adherence
to rehabilitation.
P L A I N L A N G U A G E S U M M A R Y
Participation in rehabilitation programmes that include regular exercise, can improve the quality of life for people with heart
disease
Background
Cardiac rehabilitation (CR) seeks to improve the function, health-related quality of life and well-being of people with heart disease
through a combination of activities, in particular exercise training alongside educational and psychological support. Since the mid-
2000s, the number of published Cochrane reviews has grown to six systematic reviews/meta-analyses of CR. These reviews assessed
the impact of CR on different types of heart disease (e.g. following a heart attack, heart surgery or heart failure) or different ways of
providing CR (e.g. in a hospital- or home-based setting, exercise only programmes or exercise in combination with an educational or
psychological intervention or both). The aim of the overview was to review the current CR Cochrane reviews to provide a ’friendly
front end’ to this ’portfolio’ of reviews.
Study characteristics
We searched for Cochrane reviews that analysed the data from randomised controlled trials (RCT; experiments that randomly allocate
participants to one of two or more treatment groups), which looked at the effectiveness of CR in adults with heart disease and compared
patient outcomes with a no-exercise control group. This overview summarised the findings from these reviews.
Key results
We found six high-quality Cochrane reviews that included 148 RCTs in 98,093 people who primarily had experienced a heart attack,
had undergone cardiac surgery or had chronic heart failure. The findings of this overview showed important benefits of CR participation
that included a reduction in the risk of hospital admissions, as well as improvements in health-related quality of life compared with not
undertaking rehabilitation.
Quality of the evidence
The quality of the RCTs in the included systematic reviews was variable, and limitations in their methodological quality led to
downgrading of the quality of the evidence, which varied widely by review and outcome. We make the following recommendations for
the future conduct and reporting of systematic reviews of CR.
• The scope of CR reviews needs to reflect current guidelines that recommend that CR should be based on an individually prescribed
programme of exercise training with appropriate co-interventions.
• Future CR reviews need to explore the complexity of CR using appropriate approaches to explore the association between intervention
characteristics and outcomes across trials.
• Future Cochrane CR reviews need to standardise their methods and reporting.
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B A C K G R O U N D
Description of the condition
Heart disease is a broad term used to describe a range of diseases
that affect the heart, including diseases of heart blood vessels (coro-
nary artery disease), heart rhythm problems (arrhythmias), heart
infections and congenital heart defects. Coronary heart disease
(CHD) is the most common type of heart disease and its common
symptoms are chest pain (angina) and myocardial infarction (MI).
Acute coronary syndrome refers to a range of acute CHD states
and includes unstable angina (chest pain at rest), non-ST segment
elevation MI (ST segment elevation generally absent) and ST seg-
ment elevation infarction (persistent ST segment elevation usu-
ally present). CHD can result in difficulties in functionality and
performance of everyday activities and can impair sexual function
(Racca 2010), contributing to a reduction in health-related quality
of life (HRQoL) (Gravely-Witte 2007).
CHD is now considered the leading cause of global mortality.
According to the World Health Organization (WHO), CHD ac-
counted for 12.9%of all deaths (sevenmillion deaths) and 5.8%of
total disability-adjusted life years globally in 2011 (WHO 2014).
The situation is worse in high-income countries, and it has been
estimated that CHD accounted for 24.8% of all deaths in Europe
in 2011 (WHO 2014). However, despite the overall increase in
CHD burden in high-income countries, age-adjusted mortality
for this disease is declining and over half of people diagnosed now
survive (Allender 2008). This is driven largely by preventive in-
terventions, treatments to prevent death during an acute disease
manifestation and rehabilitation interventions that prolong sur-
vival (Gaziano 2010). Conversely, morbidity is rising, with an in-
creasing number of survivors of MI (Mathers 2008), and an asso-
ciated number of cases of chronic heart failure (HF) (Kostis 1997).
The most common cause of HF is CHD. Non-ischaemic causes of
HF include hypertension and atrial fibrillation. HF is a complex
clinical syndrome that results from any structural or functional im-
pairment of ventricular filling or ejection of blood. It has been in-
creasingly recognised that HF has two sub-categories: 1. impaired
left ventricular contraction, which results in a reduced ejection
fraction (less than 35% to 50%), known as HF with reduced ejec-
tion fraction (HFREF) or ’systolic HF’; and 2. HF with preserved
ejection fraction (HFPEF) with an ejection fraction of greater than
35% to 50% and also known as ‘diastolic HF’. People with HF
experience marked reductions in their exercise capacity, which has
detrimental effects on their activities of daily living, HRQoL, and
their hospital admission rate and mortality (Go 2014). In high-
income countries, about 2% of adults have HF, but in people over
the age of 65 years, this increases to 6% to 10% (McMurray 2005;
Dickstein 2008). The prevalence and incidence of HF is steadily
increasing, with approximately 825,000 new cases annually in the
US (Go 2014). HF has a poor prognosis, with 30% to 40% of
people diagnosed dying within one year, although thereafter the
mortality is less than 10% per year (Cowie 2000; Hobbs 2007).
However, as with CHD, survival after HF diagnosis has also im-
proved (Go 2014), and in the UK there is evidence of a trend of
improved prognosis, with the six-month mortality rate decreasing
from 26% in 1995 to 14% in 2005 (Mehta 2009).
Description of the interventions
Many definitions of cardiac rehabilitation (CR) have been pro-
posed. The following definition encompasses the key concepts
of CR: “The coordinated sum of activities required to influence
favourably the underlying cause of cardiovascular disease, as well
as to provide the best possible physical, mental and social con-
ditions, so that the patients may, by their own efforts, preserve
or resume optimal functioning in their community and through
improved health behaviour, slow or reverse progression of disease”
(BACPR 2012). While exercise training is the foundation of CR,
it is recommended that ’comprehensive’ programmes also include
education (e.g. provision of information about a healthy lifestyle)
and psychological intervention (e.g. counselling to reduce stress).
CR has many of the characteristics of a ’complex intervention’ as
defined by in the Medical Research Council 2008 guidance for
developing and evaluating complex interventions, that is, 1. num-
ber of interacting components, 2. number and difficulty of be-
haviours required by people delivering or receiving the interven-
tion, 3. number and variability of outcomes and 4. degree of flex-
ibility or tailoring of the intervention permitted (non-standardis-
ation/reproducibility) (Craig 2008).
Patient education is the process by which health professionals im-
part information to patients that will alter their health behaviours
or improve their health status (Koongstvedt 2001). There is sub-
stantial variation in the delivery of patient education for cardiac
patients; it may be classroom- or home-based, group or individual,
tailored or generic. Duration and reinforcement of education also
differs between programmes. Some programmes are developed ac-
cording to validated educational theory and by trained profession-
als while others are delivered by peers.
Interventions that specifically aim to influence psychological or
psychosocial outcomes are varied and may range from organ-
isational efforts to improve patient communication and sup-
port (e.g. Jolly 1998), to empirically supported psychotherapies
used to target diagnosed psychopathology in cardiac patients (e.g.
Black 1998). Furthermore, psychological/psychosocial interven-
tions may incorporate other elements of CR such as diet and
lifestyle advice, or exercise. In some cases, the intervention may be
described as ’psychological’ only to the extent that psychological
techniques are used to further other treatment goals.
The patient groups routinely recommended for CR include peo-
ple with post-MI, post-revascularisation procedure and HF. Tradi-
tionally, CR programmes have been offered in a supervised centre-
based setting. However, many people do not receive rehabilitation
(Bethell 2008), and with uptake of CR for both CHD and HF
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currently at sub-optimal levels (Tierney 2011; Dalal 2012; NICE
2013), home-based CR programmes have been increasingly intro-
duced to widen access and participation. In addition to uptake,
maintaining longer-term adherence to CR is also a key challenge
(Daly 2002; Moore 2003), and therefore, interventions aimed at
improving patient uptake and adherence to CR programmes have
been adopted and will be investigated in this overview.
Based on current evidence, national and international guidelines
on themanagement ofCHDandHF including those by theAmer-
ican College of Cardiology (ACC)/American Heart Association
(AHA), European Society of Cardiology (ESC) and National In-
stitute for Health and Care Excellence (NICE, UK), consistently
recommend CR as an effective and safe intervention (McMurray
2012; NICE 2013; Yancy 2013).
How the intervention might work
The mechanism by which CR may work depends on the patient
group and the component of rehabilitationbeing considered.Most
mechanistic evidence is for exercise training.
For people with CHD, exercise training has direct benefits on
the heart and coronary vasculature, including myocardial oxy-
gen demand, endothelial function, autonomic tone, coagulation
and clotting factors, inflammatory markers and the development
of coronary collateral vessels (Clausen 1976; Hambrecht 2000).
However, findings of the original Cochrane review of exercise-
based CR for CHD (Jolliffe 2001) supported the hypothesis that
reductions in mortality may also be mediated via the indirect
effects of exercise through improvements in the risk factors for
atherosclerotic disease (i.e. lipids, smoking and blood pressure)
(Taylor 2006).
The precise mechanism(s) through which exercise training bene-
fits people with HF remains unclear. One explanation, applicable
to people with ischaemic causes of HF, is that exercise training
improves myocardial perfusion by alleviating endothelial dysfunc-
tion therefore dilating coronary vessels and by stimulating new
vessel formation by way of intermittent ischaemia (Piepoli 2004).
Indeed, Belardinelli and colleagues have demonstrated that aer-
obic training improves myocardial contractility and diastolic fill-
ing (Belardinelli 1998). One meta-analysis by Haykowsky et al,
demonstrated the benefits of exercise training on cardiac remod-
elling as measured by ejection fraction, end-diastolic volume and
end-systolic volume (Haykowsky 2007). Regardless of cause, there
are important neurohormonal and musculoskeletal abnormalities
in HF. Exercise training may reduce adrenergic tone and increase
vagal tone, as suggested by an assessment of variability in heart
rate. Skeletal muscle dysfunction and wasting may also respond
to exercise training (Piepoli 2004). Hambrecht et al. have demon-
strated that regular physical activity in people with HF stimulates
vasodilation in the skeletal muscle vasculature (Hambrecht 1998).
The benefits of education and psychological interventions de-
pend on changing people’s behaviour including improvements in
healthy lifestyle and changes in mood, such as reductions in de-
pression and anxiety.
Why it is important to do this overview
In 2001, Jolliffe et al. published the first Cochrane review of
CR, summarising the evidence of 32 randomised controlled trials
(RCTs) in 8440 post-MI and revascularisation patients, and con-
firming a mortality benefit of exercise-based CR (Jolliffe 2001).
With the funding support of the National Institute of Health Re-
search (NIHR, UK), since the mid-2000s, the number of pub-
lishedCochrane reviews has grown to six systematic reviews/meta-
analyses.
• Exercise-based cardiac rehabilitation for coronary heart
disease (Heran 2011).
• Exercise-based rehabilitation for heart failure (Taylor
2014b).
• Psychological interventions for coronary heart disease
(Whalley 2011).
• Patient education in the management of coronary heart
disease (Brown 2011).
• Home-based versus centre-based cardiac rehabilitation
(Taylor 2014a).
• Promoting patient uptake and adherence in cardiac
rehabilitation (Karmali 2014).
The development of the portfolio of Cochrane reviews has re-
flected many of the key areas of evolution in the provision of CR
and how this model of service delivery can differ across interna-
tional healthcare jurisdictions. These include the shift from em-
phasis on exercise therapy alone to comprehensive secondary pre-
vention including risk factor and dietary education and manage-
ment of psychological factors; the expansion of the population of
cardiac patients receiving CR services to include HF; the develop-
ment of alternative settings of CR delivery that include home pro-
vision in addition to the traditional supervised hospital- or centre-
based programmes; and the need to broaden the consideration of
the outcomes of CR to inform the needs of healthcare policy mak-
ers (e.g. impacts on hospital admission, HRQoL and healthcare
costs). This Cochrane CR review portfolio remains dynamic, with
three reviews having undergone an update in the last 12 months
(Karmali 2014; Taylor 2014a; Taylor 2014b).
The portfolio of Cochrane reviews has played an important role
in informing evidence-based policy for CR nationally and inter-
nationally, and the reviews have been cited in several key clinical
guidelines including those by the ACC/AHA, ESC and NICE,
which consistently recommend CR as a safe and effective inter-
vention (Balady 2011; Perk 2012; McKelvie 2013; NICE 2013b;
Task Force Members 2013; Yancy 2013).
Overviews of systematic reviews are a new approach to summaris-
ing evidence, synthesising results frommultiple systematic reviews
into a single usable document (Becker 2011). By providing a sin-
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gle synthesis of all relevant evidence in a particular area, overviews
may be useful for therapeutic and policy decision-making, pro-
viding a comprehensive ’friendly front end’ to the evidence, so
that the reader does not have to assimilate the data from separate
systematic reviews. Overviews can also help inform the strategic
direction of conduct and structuring of future systematic reviews.
For example, the latest version of the Cochrane review of exercise-
based CR for CHD included 47 RCTs in over 10,000 participants
and may, therefore, benefit from being organised into sub-reviews
(’splitting’) according to CHD indications (i.e. post-MI, revascu-
larisation and angina). Finally, overviews provide an opportunity
to identify potential ’evidence gaps’ and, therefore, inform areas
in which new Cochrane reviews should be prioritised.
O B J E C T I V E S
To conduct an overview of Cochrane systematic reviews to pro-
vide a contemporary review of the evidence for delivery of cardiac
rehabilitation, to identify opportunities for merging or splitting
existing Cochrane reviews, and to identify current evidence gaps
to inform new cardiac rehabilitation systematic review titles.
M E T H O D S
We conducted this overview in accordance with the recommen-
dations for Cochrane overviews (Becker 2011).
Criteria for considering reviews for inclusion
We initially included the portfolio of sixCochraneCR reviews that
were already known to us. In addition, we sought to include any
other Cochrane reviews that may inform the aims of this overview
including those that assessed the efficiency of CR services or that
compared the delivery of CR across different settings.
Types of reviews
We included Cochrane reviews and protocols currently published
in The Cochrane Library that examined the impact of CR. Given
the targeted aims of this overview, we did not consider non-
Cochrane systematic reviews.
Types of participants
We included adults aged 18 or over, with heart disease, regardless
of aetiology.
Types of interventions
For the purposes of this review, we defined CR as: exercise with
or without education with or without psychological intervention,
delivered to people with heart disease, in a hospital community or
a home-based setting.
Types of outcome
Patient-related outcomes
• Mortality:
◦ cardiovascular mortality and non-cardiovascular
mortality.
• Morbidity:
◦ MI (total MI, fatal MI and non-fatal MI);
◦ total revascularisations (coronary artery bypass graft
(CABG), percutaneous transluminal coronary angioplasty
(PTCA) and re-stenting);
◦ total hospitalisations (cardiovascular hospitalisations
and other hospitalisations);
◦ HRQoL assessed using validated instruments (e.g. 36-
item Short Form (SF-36), EQ5D).
Process-related outcomes
• Measure of uptake of, or adherence to, CR.
• Costs and cost-effectiveness.
Search methods for identification of reviews
We searched The Cochrane Database of Systematic Reviews
(2014, Issue 10) using the search strategy listed in Appendix 1.We
applied no date or language restrictions. Where reviews had been
updated, owe sought only the most recent version. We sought full
Cochrane reviews or protocols currently published that:
• examined the impact or delivery of CR;
• included adults with heart disease, regardless of aetiology;
• included exercise training interventions either alone or in
combination with an educational or psychological intervention
or both, delivered in a hospital community or a home-based
setting.
Data collection and analysis
Selection of reviews
Two authors (LA, RST) independently screened the titles and
abstracts of all of the Cochrane systematic reviews identified as
a result of the search for inclusion, and coded them as ’retrieve’
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(eligible or potentially eligible/unclear) or ’do not retrieve’. We
retrieved the full-text of selected reviews and two authors (LA,
RST) independently screened the full-text and identified reviews
for inclusion, and identified and recorded reasons for exclusion
of the ineligible reviews. We resolved any disagreements through
discussion.
Data extraction and management
We used standardised data collection forms to extract characteris-
tics of reviews and included studies and outcome data. We piloted
these forms on one review included in the overview. One author
(LA) extracted review and study characteristics and outcome data
from included reviews and a second author (RST) checked all ex-
tracted data for accuracy.We resolved disagreements by consensus.
If study level information within a published review was unclear
or missing, we clarified this by reference to the published reports
of the individual RCT. One author (LA) transferred extracted data
into the Review Manager 5 (RevMan 2014), and a second author
(RST) spot-checked data for accuracy against the systematic re-
views.
We extracted the following information from included Cochrane
reviews: review objectives or question, search time frame, inclusion
criteria (study design, population, intervention, comparator and
outcomes), source of funding and stated conflicts of interest of
review authors.
We extracted the following characteristics of the RCTs included
in each of the Cochrane reviews: number of included trials, year
of publication, population, intervention and comparator, primary
and secondary outcomes specified and collected, total duration of
study, number of study centres and location.
We sought the following outcome data:
• all-cause and disease-specific mortality;
• morbidity: fatal and non-fatal MI; percutaneous coronary
intervention (PCI); hospitalisation: overall and disease-specific;
• HRQoL assessed using validated instruments (e.g. SF-36,
EQ5D);
• measures of uptake of, or adherence to, CR; and
• costs and cost-effectiveness.
We did not re-assess the risk of bias of included studies within
reviews, but instead reported according to the review authors’ as-
sessment using The Cochrane Collaboration ’Risk of bias’ tool (in
accordance with the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). The standard ’Risk of bias’ items in-
clude: random sequence generation and allocation concealment,
description of drop-outs and withdrawals, blinding of outcome
assessment and presence of selective reporting. In addition, we
sought evidence that the groups were balanced at baseline, that
an intention-to-treat analysis was undertaken and that groups re-
ceived comparable care (apart from the intervention). Where a
’Risk of bias’ element was not reported within the review, one au-
thor (LA) assessed the original included study publication and a
second author (RST) checked the details.
Assessment of methodological quality of included
reviews
Quality of included Cochrane reviews
One author (LA) independently assessed themethodological qual-
ity of the included reviews using the ’Revised Assessment of Mul-
tiple Systematic Reviews’ (R-AMSTAR) measurement tool (Kung
2010), where the 11 domains of the original AMSTAR tool (Shea
2009) were scored between 1 and 4 and the R-AMSTAR total
score ranged from 11 to 44. We resolved any disagreements by
discussion. A second author (RST) checked the assessment.
Quality of evidence in included reviews
One author (LA) used GRADEProfiler software to assess the qual-
ity of evidence for outcomes reported in, and extracted from, each
of the reviews (GRADEpro 2008), based on the following factors:
indirectness of evidence, unexplained heterogeneity, publication
bias, risk of bias due to study design limitations and imprecision
of results (Balshem 2011). A second author (RST) checked the
assessment.
Assessment of bias in conducting the overview
We conducted the overview according to the published protocol
and we have reported any deviations from it in the Differences
between protocol and review section of this overview.
Data synthesis
The unit of analysis for this overview is the systematic reviews
(and not individual trials). The focus of the data presentation was
descriptive, with detailed tabular presentations of the extracted
review- and trial-level information outlined above. We conducted
no de novo data analysis of trial-level outcomes for this overview.
We have tabulated review-level summaries for all the outcomes
listed above from each of the included reviews. Where outcomes
were meta-analysed within a review, we extracted and reported
pooled effect sizes. Where no quantitative pooling of effect sizes
was reported, or where outcomes were reported descriptively by
single studies, we reported these results by vote counting (Bushman
1984), or using standardised language indicating direction of ef-
fect and statistical significance. For continuous outcomes, we sum-
marised data using the standardised mean difference (SMD) or
mean difference (MD) with 95% confidence interval (CI) as re-
ported in the included reviews. For dichotomous outcomes, we
presented the risk ratio (RR) or odds ratio (OR) and 95% CI as
appropriate.
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Due to the heterogeneity of populations, interventions and out-
comes in the included systematic reviews, we did not seek to com-
pare either CR interventions directly across reviews (e.g. exercise
CR versus education for CHD) or to compare interventions across
review populations (e.g. exercise CR for CHD versus exercise CR
for HF). For this reason, we did not attempt to compare outcome
results across trials using indirect network meta-analysis methods.
R E S U L T S
Identification of reviews
Figure 1 summarises the review selection process in a flow dia-
gram. Our database search yielded 92 titles from which we identi-
fied one published Cochrane review (in addition to the previously
identified six reviews) and four Cochrane review protocols that we
judged to meet the inclusion criteria. On review of the full text,
we excluded the published Cochrane review (Hulzebos 2012), as
it evaluated physical therapy with an exercise component for elec-
tive cardiac surgery patients and included only one RCT of ex-
ercise training, while the other RCTs assessed inspiratory muscle
training (Appendix 2). We judged the four Cochrane protocols
to meet the inclusion criteria (see Appendix 3). The remainder of
this overview focused on presenting the six Cochrane CR reviews.
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Figure 1. Study flow diagram.
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Description of included reviews
The characteristics of the six included Cochrane reviews are sum-
marised in Table 1 and included RCTs are summarised Table 2.
All included reviews ran searches from the inception of the elec-
tronic databases to 2013, and were published between 2011 and
2014. In all reviews, searches were limited to an RCT design and
in three cases the inclusion was limited to RCTs with follow-up of
six months or longer (Brown 2011; Heran 2011; Taylor 2014b).
In total, the included reviews contained 148 RCTs and 97,486
participants. Four RCTs were included in more than one review
(Stern 1983; Miller 1984; PRECOR 1991; Lisspers 1999). Most
included RCTs were published since themid-1990 (1970 to 1979:
4 RCTs; 1980 to 1989: 16 RCTs; 1990 to 1999: 40 RCTs; 2000
to 2009: 72 RCTs, 2010 and later: 16 RCTs). The median sample
size of RCTs ranged widely from only 16 participants (Duncan
2003) to 46,606 participants (Esposito 2008). Most RCTs were
undertaken in either Europe (69%) or North America (35%) and
were mainly single centre (79%).
Search methods
All six reviews searched the Cochrane Central Register of Con-
trolled Trials (CENTRAL), MEDLINE, MEDLINE In-Pro-
cess, EMBASE and CINAHL. In addition, four of the reviews
searched PsycINFO (Brown 2011; Heran 2011; Karmali 2014;
Taylor 2014a). Three reviews also undertook searches for ongo-
ing RCTs using trial registers (International Standard Randomized
Controlled Trial Number (ISRCTN) registry (www.controlled-
trials.com) and ClinicalTrials.gov (clinicaltrials.gov/)) and all re-
views searched for additional RCTs by manually checking the ref-
erence lists of included studies.
Participants
The types of participants included in this overview varied between
reviews. The scope of two reviews included all adults with heart
disease, regardless of indication (Karmali 2014; Taylor 2014a),
three reviews were limited to people with CHD (post-MI and
PCI) (Brown 2011; Heran 2011; Whalley 2011), and one review
was limited to HF (Taylor 2014b). Although 78% of the RCTs
that reported gender included women, the median proportion of
men included in RCTs ranged from 60% to 88% across reviews.
The mean age of participants in RCTs ranged from 46 to 87 years.
Interventions
Two of the reviews included exercise training or exercise training
alongside other interventions that included education or psycho-
logical support or both (Heran 2011; Taylor 2014b. One review
focused on psychological interventions (Whalley 2011), although
it included several RCTs that also incorporated an educational
component. One review included only RCTs with an educational
focus (Brown 2011), one included interventions to increase the
uptake and adherence to CR (Karmali 2014), and one review
compared the delivery of CR in home- and centre-based settings
(Taylor 2014a).
Outcome measures
All reviews pre-specified outcome measures that consistently in-
cluded all-cause mortality and HRQoL. Although all reviews
sought morbidity outcomes, the definition and breadth of these
outcomes varied across reviews. For example, the review by Heran
et al. stated that they sought MI (total, fatal, non-fatal), revas-
cularisations (total, CABG, PTCA, stenting) and hospitalisations
(Heran 2011), while the review by Karmali et al. reported “CHD
event rates” (Karmali 2014). Four reviews sought economic out-
comes (Brown 2011; Heran 2011; Taylor 2014a; Taylor 2014b),
and two reviews reported collected uptake or adherence data
(Karmali 2014; Taylor 2014a).
Data analysis
Five of the six reviews included meta-analyses of mortality and
morbidity outcomes. The review by Karmali et al. pre-stated that
heterogeneity (participants, interventions andoutcomes), together
with the small number of studies identified, precluded undertak-
ingmeta-analysis (Karmali 2014).Given the heterogeneity inmea-
sures, only one review used meta-analysis to pool HRQoL data
across RCTs (Taylor 2014b), the other reviews used a descriptive
or vote counting approach to summarise outcomes. This was also
the case for uptake and adherence and economic outcomes. Two
of the reviews undertook meta-regression analyses to explore how
the impact of interventions varied across participant and RCT
characteristics (Heran 2011; Taylor 2014b).
Methodological quality of included reviews
Based on our assessments using the R-AMSTAR tool, all included
reviews scored between 35 and 41 (out of a possible maximum of
44) andwe deemed themof highmethodological quality (seeTable
3). None of the reviews stated that journals were hand or manually
searched and only one stated that searches were supplemented by
consulting books or experts in the field. Two reviews were marked
down based on inadequate reporting of the publication status of
their included studies. None of the reviews rated the quality of
evidence based on a characterised instrument such as GRADE,
and while all reviews used The Cochrane Collaboration ’Risk of
bias’ tool, most were marked down as they did not refer to the
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quality of included studies in formulating recommendations. The
two weaknesses identified across reviews by R-AMSTAR were the
lack of an explicit statement on the impact of findings on clinical
practice guidelines and the failure to assess the sources of support
or conflict of interest in the included RCTs.
Risk of bias of included randomised controlled trials
All six Cochrane reviews used the core items of The Cochrane
Collaboration ’Risk of bias’ tool (see Table 4). A consistent find-
ing across reviews was that the included RCTs often did not give
enough detail to assess the adequacy of their potential risk of bias.
Where details were reported, the quality of RCTs appeared to
vary considerably across the risk of bias items. Across all reviews,
only a minority of RCTs were judged to be ’adequate’ in terms
of sequence generation (31%), sequence concealment (29%) and
outcome blinding (24%). Other aspects of RCT quality (baseline
balance, selective reporting, loss of follow-up, intention-to-treat
analysis and groups receiving same intervention) were judged to
be better (greater than 50% of all included RCTs achieving ade-
quacy).
Quality of evidence from randomised controlled trials
in included reviews
The quality of the evidence reported by the RCTs in the included
reviews was rated using the GRADE method. The quality of the
evidence varied widely (by review and by outcome) and ranged
from very low to moderate. See Table 5; Table 6; Table 7; Table
8; and Table 9 for details.
Effect of interventions
Table 10 summarises the outcome results across included
Cochrane reviews.
Exercise-based cardiac rehabilitation for coronary
heart disease (Heran 2011)
The Heran et al. review undertook database searches up to De-
cember 2009 with the inclusion of RCTs with six months or more
of follow-up comparing CR with no CR control (Heran 2011).
The review included 47 RCTs with 10,794 participants who were
mainly post-MI or post-PCI, predominantly men (median 88%)
and with a median mean age of 55.0 years (see Table 2). CR pro-
grammes differed considerably across RCTs in duration (range one
to 30 months), frequency (one to seven sessions/week) and session
length (20 to 90 minutes/session), and included both exercise-
only CR programmes and comprehensive CR programmes (ex-
ercise plus psychological or education intervention, or both). We
judged this review to be of good methodological quality, with an
R-AMSTAR score of 39.
With follow-up of six to 12 months, there was a trend towards
a reduction in total mortality (RR 0.82; 95% CI 0.67 to 1.01;
low GRADE rating) and no difference was seen between groups
in cardiovascular mortality (RR 0.93; 95% CI 0.71 to 1.21; low
GRADE rating). However, with follow-up of 12 months or more,
CR reduced overall (RR 0.87; 95% CI 0.75 to 0.99; moderate
GRADE rating) and cardiovascular mortality (RR 0.74; 95% CI
0.63 to 0.87; moderate GRADE rating). There was no evidence of
a difference in risk of reinfarction or PCI betweenCR and control.
Ten of the included studies (2379 participants) reported hospi-
tal admissions. In the shorter term (less than 12 months’ follow-
up), hospital admissions were reduced compared with control (RR
0.69; 95% CI 0.51 to 0.93; moderate GRADE rating) but there
was no evidence of a reduction in the longer term (greater than 12
months’ follow-up) (RR 0.98; 95% CI 0.87 to 1.11; low GRADE
rating). There was no evidence of heterogeneity of effect across
RCTs for any of the mortality or morbidity outcomes. Univari-
ate meta-regression showed no differences in intervention effects
across various participant and RCT characteristics in mortality or
morbidity outcomes. In seven out of 10 RCTs, there was evidence
of a significantly higher level of HRQoL with CR than control.
Three of the included studies reported data on patient costs, their
direct comparison limited by differences in currencies and the time
when the studies were conducted.
Exercise-based rehabilitation for heart failure (Taylor
2014b)
The Taylor et al. review was updated with searches up to March
2013 and included 33 RCTs with six months ormore of follow-up
comparing CR with no CR control in 4676 participants with HF
(Taylor 2014b). Participants were predominantly men (median
80%)with amedian age of 60 years, had a reduced ejection fraction
(HFREF less than 40% to 45%) and New York Heart Association
classification I to III (see Table 2). The exercise regimen ranged
widely across RCTs from a session duration of 15 to 120 minutes,
from one to seven sessions/week, and from intensity of 40% to
80% of maximal heart rate (or equivalent) over a period from one
to 120 months and included both exercise-only CR programmes
and comprehensive CR programmes (exercise plus psychological
or education (or both) intervention). We judged this review to be
of good methodological quality, with an R-AMSTAR score of 39.
There was no evidence of difference in pooled mortality between
intervention and controls at six- to 12-month follow-up (RR 0.93;
95% CI 0.69 to 1.27; low GRADE rating). However, in the six
RCTs with more than 12 months’ follow-up, there was a trend
towards a reduction in all-cause mortality with exercise (RR 0.88;
95% CI 0.75 to 1.02; low GRADE rating). Compared with con-
trol, exercise training reduced the risk of overall hospitalisation
(RR 0.75; 95% CI 0.62 to 0.92; moderate GRADE rating) and
HF-specific hospitalisation (RR 0.61; 95% CI 0.46 to 0.80; mod-
erate GRADE rating) although there was no difference in all hos-
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pital admissions at beyond 12-month follow-up (RR 0.92; 95%
CI 0.66 to 1.29; very low GRADE rating). Exercise resulted in a
clinically important improvement in the Minnesota Living with
Heart Failure (MLWHF) questionnaire (MD -5.8 points, -9.2 to -
2.4; very low GRADE rating) although there was evidence of high
levels of statistical heterogeneity (I2 = 70%). Univariate meta-re-
gression analysis showed that these benefits in hospitalisation and
HRQoL were independent of participant characteristics (age, gen-
der, left ventricular ejection fraction), type of CR (exercise only
versus comprehensive CR), exercise-based CR regimen, length of
follow-up, overall risk of bias, RCT publication date, single ver-
sus multicentre RCT or CR setting (home versus centre-based).
There was limited evidence to support CR for people with HF
with HFPEF (three RCTs, undefined participant number) and
when exclusively delivered in a home-based setting (five RCTs,
521 participants).
Three RCTs reported economic data. Although no group differ-
ences in costs or outcomes across these three studies achieved sta-
tistical significance, two studies indicated CR to be cost-effective
(USD1773 per life-year saved; Georgiou 2001), and a mean gain
in quality-adjusted life-year (QALY) of 0.03 at an additional mean
cost of USD1161 per person (Flynn 2009).
Psychological interventions for coronary heart
disease (Whalley 2011)
The Whalley et al. review undertook searches up to January 2009
with the inclusion of RCTs of psychological interventions com-
pared with usual care in people with a diagnosis coronary artery
disease (Whalley 2011). The review included 24 RCTs in 9296
participants who were predominantly low-risk post-MI or PCI,
male (median 84%) with a median mean age of 57 years (see Table
2). The review authors reported substantial variability in the in-
tensity of treatments offered across RCTs; the mean number of
hours spent in treatment was 26.1 hours (2.4 to 96). Included
trials applied both psychological-only CR programmes and com-
prehensive CR programmes (psychological and education inter-
ventions).
Most interventions were based on group therapy sessions or com-
prised a mix of group and individual session; only four RCTs used
treatments that were delivered only on an individual basis. We
judged the review to be of good methodological quality, with an
R-AMSTAR score of 39. There was evidence of a trend towards a
reduction in all-cause mortality (RR 0.89; 95% CI 0.75 to 1.05;
low GRADE rating) and fewer cardiac deaths with psychological
intervention (RR 0.80; 95% CI 0.64 to 1.00; low GRADE rat-
ing). There were significant effects on occurrence of revasculari-
sation (RR 0.95; 95% CI 0.80 to 1.13; moderate GRADE rat-
ing) and non-fatal re-infarction (RR 0.87; 95% CI 0.67 to 1.13;
low GRADE rating). One of seven studies reported superiority
in HRQoL with psychological intervention compared with usual
care.
Patient education in the management of coronary
heart disease (Brown 2011)
The Brown et al. review undertook searches up to August 2010
with the inclusion of RCTs (with follow-up of six months or
more) of patient education interventions comparedwith usual care
(Brown 2011). The review included 13 RCTs in 68,556 partici-
pants with HF, stable angina, and post-MI and PCI who were pre-
dominantly male (median 60%) with a median mean age of 62.0
years (see Table 2). Interventions varied considerably across RCTs,
with some providing group sessions, some individualised educa-
tion and others both. Educational regimen ranged from two clinic
visits to a four-week residential stay with 11 months of follow-up
sessions. All included trials were limited to educational interven-
tions and did not use other CR interventions of exercise or psy-
chological support. We judged this review to be of good method-
ological quality, with an R-AMSTAR score of 41. There was no
evidence of a significant difference in total mortality (RR 0.79;
95% CI 0.55 to 1.13; moderate GRADE rating) or morbidity
(MI: RR 0.63; 95% CI 0.26 to 1.48, low GRADE rating; CABG:
RR 0.58; 95% CI 0.19 to 1.71, low GRADE rating; hospitalisa-
tion: RR 0.83; 95% CI 0.65 to 1.07, moderate GRADE rating).
Across the 11 studies that reported HRQoL, while there was no
consistent difference in HRQoL total or domain score at follow-
up between intervention and control, five RCTs demonstrated sta-
tistically significant differences in some domains in favour of in-
tervention. Five RCTs reported healthcare utilisation and costs.
Given the small number of included RCTs, the authors deemed
meta-regression analysis inappropriate.
Home-based versus centre-based cardiac
rehabilitation (Taylor 2014a)
The Taylor et al. review was updated with searches up to Novem-
ber 2012 and sought to include RCTs comparing home-based and
centre-based CR (Taylor 2014a). Home-based CR was defined as
“a structured programmewith clear objectives for the participants,
including monitoring, follow up visits, letters or telephone calls
from staff, or at least self-monitoring diaries” and centre-based CR
was defined as “based in a variety of settings (e.g. hospital phys-
iotherapy department, university gymnasium, community sports
centre)”. The review included 17 RCTs in 2172 people with stable
angina, HF and post-MI and PCI who were predominantly male
(median 80%) with a median mean age of 60 years (see Table
2). Most RCTs compared comprehensive programmes (i.e. exer-
cise training plus education or psychological (or both) interven-
tions) with the exercise components differing considerably across
RCTs in duration (range 1.5 to six months), frequency (one to five
sessions per week) and session length (20 to 60 minutes per ses-
sion). Included trials applied both exercise-only CR programmes
and comprehensive CR programmes (exercise plus psychological
or education (or both) intervention). We judged the review to
be of good methodological quality, with an R-AMSTAR score of
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40. There was evidence of a difference in mortality at three to
12 months’ follow-up between home and centre CR (RR 0.79;
95% CI 0.43 to 1.47; low GRADE rating). Four studies reported
cardiac events, but no pooling of data was possible due to dif-
ferences in the nature of the reported events. There was no evi-
dence of difference between the two settings in overall or domain
HRQoL scores in individual RCTs. Four out of the 14 studies
reporting adherence found superior adherence in the home-based
compared with centre-based CR setting. There was no consistent
difference in the healthcare costs associated with the two forms of
CR, although difference in currencies and timing of studies meant
that it was not possible to compare costs directly across studies. In
three of the four studies, the healthcare costs associated with CR
were lower for the home-based than centre-based programmes,
although this was significantly lower in only one study (GBP170
per participant versus GBP200 per participant; difference of -GBP
30, 95% CI -45 to -12; P value < 0.0001; Dalal 2007). Jolly et al.
found that home-based CR was more expensive than centre-based
CR (GBP198 per participant versus GBP157 per participant; P
value < 0.05; Jolly 2007), although the costs of two would be
the same if participant travel costs and travel time were included.
Given the small number of included RCTs, the authors deemed
meta-regression analysis inappropriate.
Promoting participant uptake and adherence in
cardiac rehabilitation (Karmali 2014)
The Karmali et al. review was updated with searches up to January
2013 and sought to include RCTs of interventions to increase CR
uptake (participants attendance or enrolment in CR programmes)
or adherence (extent to which the participant’s behaviour con-
curred with the advice given by health professional, e.g. to at-
tend CRmeetings or to undertake independent exercise) (Karmali
2014). The review included 18 RCTs in 2505 participants with
HF, stable angina, and post-MI and PCI who were predominantly
male (median 84%). We judged this review to be of good method-
ological quality, with an R-AMSTAR score of 35. Meta-analysis
and meta-regression was not undertaken due to heterogeneity in
outcome definition across RCTs. Of the 10 RCTs (1658 partici-
pants) evaluating the effectiveness of interventions to increase up-
take of CR, eight reported higher rates of CR uptake in the inter-
vention group (range 11% to 46%). Uptake was variously defined
in these studies as enrolment in CR, attendance at a variety of time
points or by number of sessions over a 12-week period. Interven-
tions that improved uptake of CR included: structured nurse- or
therapist-led contacts, early appointments after discharge, motiva-
tional letters, gender-specific programmes and intermediate-phase
programmes for elderly people. Three out of eight RCTs (1167
participants) found significant improvements in adherence to CR
although there was no evidence of an improvement in HRQoL.
Interventions that improved adherence included self monitoring
of activity, action planning and tailored counselling by CR staff.
Although data were limited, there was no evidence of a difference
in mortality or morbidity with uptake or adherence interventions.
No RCTs reported on costs or cost-effectiveness.
D I S C U S S I O N
Summary of main results
CR programmes have become an integral part of the standard of
care for people with heart disease. The scope of contemporary
CR has shifted from exercise interventions alone to more compre-
hensive secondary prevention programmes that include risk factor
education and psychological support. This overview identified six
Cochrane systematic reviews of RCTs that have assessed the out-
comes of various aspects of the delivery of CR and its component
interventions. The key outcome findings of our overview were:
• exercise-based CR in low-risk people with HF and after MI
or PCI, is safe, with no increase in short-term mortality, and
effective in terms of reductions in the risk of hospital admission
and improvements in patient HRQoL, compared with control.
While there was considerable evidence of heterogeneity across
included primary studies in both the characteristics of the
evaluated CR programmes and also across the included
participants, the outcome benefits of CR in terms of HRQoL
and reduced hospitalisation appeared to be independent of these
programme and participant characteristics;
• psychological-based and education-based interventions
alone appear to have little or no impact on mortality or
hospitalisation, but may improve HRQoL of people with CHD
in comparison with usual care alone;
• home-based and centre-based programmes seem to be
equally effective in improving the outcomes of exercise-based CR
in low-risk people after MI or post-revascularisation or with HF.
Healthcare costs of the two forms of CR were similar,
presumably as any cost reduction in delivering the intervention
in the home was offset by the associated costs of delivering
individual nursing care; and
• uptake of CR programmes was only weakly supported by
interventions designed to improve adherence to CR programmes.
Overall completeness and applicability of
evidence
There are a number of published non-Cochrane systematic reviews
of CR (Oldridge 1988; O’Connor 1989; Brown 2003; Piepoli
2004; Haykowsky 2007; Hwang 2009; Lawler 2011; Oldridge
2012). Given that our focus was Cochrane reviews, we acknowl-
edge that this overview cannot be regarded as an all-inclusive sum-
mary of the evidence base for CR. However, by focusing on high-
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quality Cochrane reviews, we believe this overview potentially pro-
vides a least biased estimate of the impact of CR.
Quality of the evidence
The included Cochrane systematic reviews were generally of high
quality and three had been updated with a literature search since
2011 (Karmali 2014; Taylor 2014a; Taylor 2014b. However, the
quality of the primary RCTs in the included systematic reviewswas
variable. The main sources of bias in the primary studies were in-
adequate reporting of allocation concealment and randomisation
methods and lack of outcome blinding. These limitations in the
methodological quality led to the downgrading of the quality of
the evidence, which varied by outcome within each review. Other
reasons for downgrading the evidence included heterogeneity or
inconsistency of effect, and imprecision of results. Another poten-
tial source of inconsistency that was not reported in the reviews
was differential use of outcome data by RCTs (i.e. some studies
analysed only post-interventional data while others measured pre-
post change).
Potential biases in the overview process
This overview included RCTs conducted between 1974 and 2013.
During this time, there have beenmajor advances in medical man-
agement, such as the increased use of statins since the mid-1990s.
Indeed, it has been hypothesised that major advances in post-MI
medical management since the mid-2000s has led to a reduction
in the incremental effect on mortality of CR compared with usual
care alone (Taylor 2012). This decrement in mortality benefit as-
sociated with CR was supported by the Rehabilitation After My-
ocardial Infarction Trial (RAMIT), which was published after the
search cut of the exercise-based CR for CHD Cochrane review.
This trial randomised 1813 participants in 14 hospitals in Eng-
land and Wales to receive either comprehensive CR or usual care
and found no difference in all-cause mortality at two years (RR
0.98; 95% CI 0.74 to 1.30) or after seven to nine years (RR 0.99;
95% CI 0.85 to 1.15) (West 2012). This RCT was published after
the search cut off of the exercise-based CR for CHD Cochrane
review.
A potential strength of an overview is that it can provide an op-
portunity to undertake indirect comparisons across interventions
that might not be included in single systematic reviews using
mixed treatment comparisons and network meta-analysis meth-
ods (Becker 2011; Mills 2013). In brief, an indirect comparison
involves the comparison of two (or more) interventions via one
or more common comparator. For example, we may seek to com-
pare the impact of exercise-based interventions and psychological-
based interventions via the combination of RCTs of exercise-based
intervention versus usual care with RCTs of psychological-based
intervention versus usual care.However, for the intervention effect
determined using an indirect comparison to be valid and equiva-
lent to the intervention effectmeasured using a direct comparison,
the sets of RCTs used to obtain the indirect comparison need to be
sufficiently similar in their characteristics (i.e. patient population,
intervention, comparator and outcomes across trials need to be
similar - the transitivity assumption) (Cipriani 2013). Given the
substantial heterogeneity in the populations of the included CR
RCTs, not only between, but also within the included CR system-
atic reviews, we deemed indirect comparisons as inappropriate in
the case of this overview. Based on the same reasoning, readers
of this overview need to apply considerable caution in taking an
informal indirect comparison approach and comparing the results
for a given outcome across reviews.
Agreements and disagreements with other
studies or reviews
In 2012, Oldridge undertook an overview of meta-analyses of CR
in people with CHD (Oldridge 2012). Given that this overview
included both Cochrane and non-Cochrane meta-analyses pub-
lished since 2000, there is considerable overlap in findings and
conclusions with the present overview. One important difference
between the two overviews is the conclusion of a reduction in all-
cause and cardiovascular mortality with CR in the overview by
Oldridge (Oldridge 2012). This mortality benefit was primarily
seen in three non-Cochrane meta-analyses (Taylor 2004; Clark
2005; Lawler 2011), while the Cochrane review found a statisti-
cally significant reduction in all-cause and cardiac mortality only
at follow-up of greater than 12 months (Heran 2011).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence compiled by this overview supports current interna-
tional clinical guidelines that state that the addition of cardiac re-
habilitation (CR) to medical management is effective (improving
health-related quality of life (HRQoL) and reducing the risk of fu-
ture hospitalisations) and safe (with no increase in short-termmor-
tality), compared with a no exercise training control, for clinically
stable participants following myocardial infarction (MI) or per-
cutaneous coronary intervention (PCI) or who have heart failure
(Balady 2011; Perk 2012; McKelvie 2013; Task Force Members
2013; NICE 2013; Yancy 2013). Future randomised controlled
trials (RCTs) of CR need to improve their reporting methods and
better reflect the real world practice including the recruitment of
higher-risk participants and consideration of contemporary mod-
els of CR delivery, and identify effective interventions for enhanc-
ing adherence to rehabilitation.
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Implications for research
Based on this overview, and taking account of recent guidelines for
the conduct of systematic review of complex interventions (Weir
2012; Petticrew 2013), we make the following recommendations
for the conduct of future CR systematic reviews:
• Scope of reviews: the scope of CR reviews needs to reflect
current guidelines that consistently recommend that CR should
be based on an individually prescribed programme of exercise
training with appropriate co-intervention including
psychological or educational interventions (BACPR 2012;
McMurray 2012; NICE 2013; Yancy 2013).
• Handling of the complexity of CR: given that CR is a
complex intervention, a key challenge of systematic reviews of
CR is taking account of the potential heterogeneity in CR
interventions (content and methods of delivery) and the
population of people who receive CR. Future reviews of CR
need to explore this complexity using approaches that include
stratification (’splitting’) of outcome results by patient indication
(e.g. post-MI versus post-PCI) or intervention type (i.e. exercise
training only versus comprehensive CR interventions); reporting
within RCT subgroup analyses; and use of meta-regression to
explore the association between intervention characteristics and
outcomes across trials. Consideration should also be given to the
appropriate use of indirect comparison methods (Bucher 1997)
in reviews or broadening the inclusion criteria of reviews to
include active comparator arms of RCTs that would allow
assessment of the comparative effectiveness of different CR
interventions (or both). Theory-based approaches to systematic
reviews of CR are also needed (Gardner 2010).
• Consistency in review conduct and reporting: to facilitate
comparison across CR systematic reviews and the efficient future
update of this overview, future Cochrane CR reviews need to
standardise their methods and reporting, including the reporting
of included RCT characteristics, risk of bias assessment criteria,
outcomes and evidence synthesis approaches.
In addition to the current Cochrane CR reviews that are in
protocol and title stage (Devi 2011; Euler 2013; Sibilitz 2013;
Mechta-Nielsen 2014; Risom 2014), consideration should be
given to new Cochrane titles to fill the CR evidence gaps identi-
fied by this overview, including ’exercise-based CR for post-car-
diac transplantation’ and ’exercise-based CR for congenital heart
disease’.
This overview also highlights several potential areas for consid-
eration in the conduct of future RCTs of CR. RCT recruitment
criteria need to reflect the real world of CR delivery better, which
includes people at higher risk who are older, female and from a
broader range of ethnicities and socio-economic groups. Report-
ing of trial methods should be improved, with greater details of
the process of randomisation and outcome blinding, more precise
description of the intervention, and consistency in the collection
and reporting of outcome measures, including the use of validated
HRQoL instruments, cardiac-related events, re-admissions and
costs. Finally, as noted by Clark and colleagues, future RCTs need
to “open the black box” of CR better (Clark 2013). In other words,
to determine the incremental benefits of the various components
of CR requires future RCTs to provide more precise descriptions
of their CR interventions so these comparisons can be more ex-
plicitly and reliably undertaken in future systematic reviews. One
publication provides researchers and clinicians with a framework
to improved reporting of intervention detail (Hoffmann 2014).
In addition, the design of future RCTs should consider ’head-to-
head’ comparisons of different combinations of CR interventions
(e.g. an ’exercise-only’ CR intervention compared with ’exercise
plus’ CR intervention).
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A D D I T I O N A L T A B L E S
Table 1. Summary of included Cochrane review characteristics
Review short ti-
tle
(reference)
Exercise for
CHD
(Heran 2011)
Exercise for HF
(Taylor 2014b)
Psychological
for CHD
(Whalley 2011)
Education for
CHD
(Brown 2011)
Home vs. centre
(Taylor 2014a)
Uptake and ad-
herence
(Karmali 2014)
Main objective To
determine the ef-
fectiveness of ex-
ercise-based CR
(exercise training
alone or in com-
bi-
nation with psy-
chosocial or edu-
ca-
tional interven-
tions) on mor-
tality, morbidity
and
HRQoL of peo-
ple with CHD
Todetermine the
effective-
ness of exercise-
based interven-
tions compared
with usual medi-
cal care by focus-
ing on mortality,
hospital admis-
sion rate, mor-
bidity and
HRQoL in peo-
ple with HF
Todetermine the
independent ef-
fects of psycho-
logical interven-
tions in people
with CHD
To
assess the effects
of patient educa-
tion on mortal-
ity, morbid-
ity, HRQoL and
healthcare costs
in people with
CHD
Todetermine the
effective-
ness of home-
based CR pro-
grammes com-
pared with su-
pervised centre-
based
CR on mortal-
ity and morbid-
ity, HRQoL and
modifiable car-
diac risk factors
in people with
CHD
Todetermine the
harms and ben-
efits of interven-
tions to increase
patient up-
take of, and ad-
herence to, CR
Search time
frame
November
2000 to Decem-
ber 2009
2008 to March
2013
2001 to January
2009
1990 to August
2010
2008 to Novem-
ber 2012
2008 to January
2013
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Table 1. Summary of included Cochrane review characteristics (Continued)
Study design RCTs (follow-up
≥ 6 months)
RCTs (follow-up
≥ 6 months)
RCTs (no mini-
mum follow-up)
RCTs (follow-up
≥ 6 months)
RCTs (no mini-
mum follow-up)
RCTs (no mini-
mum follow-up)
Population Inclusion
Post-MI
Post revasculari-
sation
CHD defined by
angiography
Exclusion
Heart valve
surgery
HF
Heart transplan-
tation
CRT or ICD im-
plant
Inclusion
HF
Exclusion
Previous CR
Inclusion
Post-MI
Post revasculari-
sation
Angina
CHD defined by
angiography
Exclusion
None
Inclusion
Post-MI
Post revasculari-
sation
Angina
CHD defined by
angiography
Inclusion
Post-MI
Post revasculari-
sation
Angina
HF
Exclusion
Heart transplan-
tation
CRT or CD im-
plant
Previous CR
Inclusion
Post-MI
Post revasculari-
sation
Angina
HF
CHD
Exclusion
Heart transplan-
tation
CRT or ICD im-
plant
Intervention Exercise training
with or without
the addition of
psychosocial or
educational
interventions (or
both)
Exercise training
with or without
the addition of
psychosocial or
educational
interventions (or
both)
Psychological in-
terventions
delivered by
healthcare work-
ers with specific
training in psy-
chological tech-
niques
Patient
education inter-
ventions involv-
ing direct con-
tact with a health
professional and
including struc-
tured knowledge
transfer about
CHD
CR programmes
delivered in a
home-based set-
ting
CR plus any in-
tervention with
the specific aim
of increasing pa-
tient uptake of,
or adherence to,
CR or any of its
component parts
Comparator No exercise
training control
that could in-
clude psycholog-
ical, educational
interventions,
standard medical
care or a combi-
nation
No exercise
training control
that could in-
clude psycholog-
ical, educational
interventions,
standard medical
care or a combi-
nation
No
psychological in-
tervention con-
trol that could
include exercise
interventions or
standard medical
care
No education in-
tervention con-
trol that could
include exercise
interventions or
standard medical
care
CR programmes
delivered in a
centre-based set-
ting
CR programmes
without the in-
tervention
Outcomes • Mortality
(total, CV, non-
CV)
• MI (total,
fatal, non-fatal)
• Revascularisations
(total, CABG,
PTCA, re-
stenting)
• Mortality
(total, HF and
sudden death)
• Hospitalisation
(total, HF)
• HRQoL
• Economic
(costs and cost-
effectiveness)
• Mortality
(total and CV)
• Morbidity
(non-fatal MI)
• Revascularisation
(CABG and
PTCA)
• Psychological
• Mortality
(total, CV and
non-CV)
• Total CV
events
• MI (fatal
or non-fatal, or
both)
• Other fatal
• Mortality
(total and CV)
• Morbidity
(reinfarction,
revascularisa-
tion, cardiac-
associated
hospitalisation)
• Exercise
Uptake of, or ad-
herence to, CR
(primary)
• Mortality
(total)
• Morbidity
• Risk factors
(smoking
behaviour, blood
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Table 1. Summary of included Cochrane review characteristics (Continued)
• Hospitalisations
(total, CV,
other)
• HRQoL
• Economic
(costs and cost-
effectiveness)
well-being
anxiety,
depression,
stress and Type
A
• Behaviour/
hostility
• HRQoL
or non-fatal (or
both) CV events
• Revascularisations
(CABG, PTCA
with or without
stenting)
• Hospitalisations
(cardiac-related)
• HRQoL
• Withdrawals/
drop-outs
• Economic
(healthcare costs
and cost-
effectiveness)
capacity
• Risk factors
(smoking
behaviour, blood
lipid levels,
blood pressure)
• HRQoL
• Adverse
events
(withdrawal
from the exercise
programme)
• Adherence
to rehabilitation
• Economic
(health service
use, costs and
cost-
effectiveness)
lipid levels,
blood pressure)
• HRQoL
• Economic
(healthcare costs
and cost-
effectiveness)
• Any
beneficial or
adverse events
Funding source NIHR, UK
Cochrane Col-
laboration Pro-
gramme Grant,
UK
None specified Depart-
ment of Social
Medicine, Uni-
versity of Bristol,
UK
Health Services
Research Focus,
University of
Wales College of
Medicine, UK
British Heart
Foundation, UK
ESCR, UK
NIHR, UK
Cochrane Col-
laboration Heart
Programme
Grant, UK
NIHR, UK
Cochrane Col-
laboration Pro-
gramme Grant,
UK
NIHRCochrane
Heart
Programme
grant, UK
Transparency of
the
National Health
SystemDrug Re-
imburse-
ment Decisions,
Poland, EU
NIHR
programme
grant, UK
Authors’ decla-
rations of inter-
est
Authors were au-
thors of the origi-
nal Cochrane re-
view. RST was
a co-investigator
on a number of
CR RCTs
- None declared None declared RSTwas a co-au-
thor of the origi-
nal Cochrane re-
view and
was a co-investi-
gator on a num-
ber of CR RCTs
None declared
CABG: coronary artery bypass graft; CAD: coronary artery disease; CHD: coronary heart disease; CR: cardiac rehabilitation; CRT:
cardiac resynchronisation therapy; CV: cardiovascular; ESCR: Economic and Social Research Council; HF: heart failure; HRQoL:
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health-related quality of life; ICD: implantable cardioverter defibrillator; MI: myocardial infarction; NIHR: National Institute of
Health Research; PTCA: percutaneous transluminal coronary angioplasty; RCT: randomised controlled trial.
Table 2. Summary of characteristics of included RCTs
Review short ti-
tle
(reference)
Exercise for
CHD
(Heran 2011)
Exercise for HF
(Taylor 2014b)
Psychological
for CHD
(Whalley 2011)
Education for
CHD
(Brown 2011)
Home vs. centre
(Taylor 2014a)
Uptake and ad-
herence
(Karmali 2014)
RCTs (participants)
Number 47 RCTs
(10,794)
33 RCTs
(4740)
24 RCTs
(9296)
13 RCTs
(68,556)
17 RCTs
(2172)
18 RCTs
(2505)
Nature of intervention*
Exercise only 17 21 0 0 6 Interventions
aimed at increas-
ing patient up-
take of CR (10
RCTs)
Interven-
tions designed to
increase ad-
herence to exer-
cise (7 RCTs) or
supervisedCR (1
RCT)
Psychological
only
0 0 14 0 0
Education only 0 0 0 13 0
> 1 intervention 29* 12 10 (psychologi-
cal and educa-
tion)
0 11
Sample size
Median (range) 142
(28 to 2304)
54
(19 to 2331)
133
(44 to 2481)
288
(87 to 46,606)
104
(20 to 525)
110
(16 to 597)
Intervention duration [months]
Median (range)
months
3 (1 to 30) 6 (1 to 120) NR 6 (1 to 30) 3 (1.5 to 6) NR
Publication year (number of RCTs)
1970-1979 2 0 2 0 0 0
1990-1999 11 0 4 0 1 2
1990-1999 20 5 8 4 2 3
2000-2009 14 20 10 9 11 8
2010+ 0 8 0 0 3 5
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Table 2. Summary of characteristics of included RCTs (Continued)
% male
Median (range) 88 (0 to 100) 80 (36 to 100) 84 (0 to 100) 60 (0 to 100) 80 (60 to 100) 84 (0 to 100)
% white
Median (range) NR 85 (60 to 100)
from 8 RCTs
NR 86 (55 to 97)
from 6 RCTs
80 from 1 RCT 79 (43 to 95)
from 6 RCTs
Age (years)
Median (range) 55 (49 to 70) 60 (51 to 81) 57 (51 to 62) 62 (51 to 73) 60 (52 to 69) 62 (51 to 77)
Indication (number of RCTs)
MI only 28 0 10 2 4 4
Angina only 1 0 1 1 0 0
Revascularisa-
tion only
1 0 4 2 4 0
MI or revascular-
isation (or both)
4 0 4 1 5 3
MI or angina 4 0 2 0 0 3
Mixed CHD 9 0 2 4 0 7
HF 0 33 0 3 CHD or HF 3 1
Arrhythmia 0 0 1 0 1 0
Study location (number of RCTs (%))
Europe 20 (43) 20 (64) 11 (46) 7 (54) 10 (58) 6 (33)
North America 3 (6) 11 (30) 11 (46) 6 (46) 5 (29) 11 (61)
Asia/Australia 7 (15) 1 (3) 2 (8) 0 1 (6) 1 (6)
Other - 1 (3) 0 0 1 (6) 0
NR 17 (36) 0 0 0 0 0
Single centre
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Table 2. Summary of characteristics of included RCTs (Continued)
Number of
RCTs (%)
23 (49) 30 (91) 8 (33) 4 (31) 15 (88) 10/16 (63)**
Follow-up duration [months]
Median (range) 24 (6 to 120) 6 (6 to 120) NR 18 (6 to 60) 6 (2 to 72) 3 (1.5 to 12)
CHD: coronary heart disease; HF: heart failure; MI: myocardial infarction; NR: not reported; RCT: randomised controlled trial.
* 1 RCT randomly assigned to exercise-only or comprehensive intervention.
** 2 studies were unavailable to us as they were unpublished degree dissertations.
Table 3. R-AMSTAR assessment of included systematic reviews
Review short ti-
tle
(reference)
Exercise for
CHD
(Heran 2011)
Exercise for HF
(Taylor 2014b)
Psychological
for CHD
(Whalley 2011)
Education for
CHD
(Brown 2011)
Home vs. centre
(Taylor 2014a)
Uptake and ad-
herence
(Karmali 2014)
1. Was an ’a priori’ design provided?
(A) ’a priori’ de-
sign
Yes Yes Yes Yes Yes Yes
(B) Statement of
inclusion criteria
Yes Yes Yes Yes Yes Yes
(C) PICO/PIPO
re-
search question
(population, in-
tervention, com-
parison, predic-
tion, outcome)
Yes Yes Yes Yes Yes Yes
Score 4 4 4 4 4 4
2. Was there duplicate study selection and data extraction?
(A) There should
be at least 2 inde-
pendent data ex-
tractors as stated
or implied
Yes *Yes *Yes *Yes *Yes Yes
(B) Statement of
recog-
nition or aware-
ness of consen-
Yes Yes Yes Yes Yes Yes
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
sus procedure for
disagreements
(C) Disagree-
ments among ex-
tractors resolved
properly as
stated or implied
Yes Yes Yes Yes Yes Yes
Score 4 4 4 4 4 Yes
3. Was a comprehensive literature search performed?
(A) At
least 2 electronic
sources should
be searched
Yes Yes Yes Yes Yes Yes
(B)
The report must
include years and
databases
used (e.g. CEN-
TRAL,
MEDLINE,
EMBASE)
Yes Yes Yes Yes Yes Yes
(C) Keywords or
MESH terms (or
both)
must be stated
AND where fea-
sible the search
strategy outline
should be pro-
vided such that
one can trace the
filtering process
of the included
articles
Yes Yes Yes Yes Yes Yes
(D) In addition
to the electronic
databases
(PubMed,
MEDLINE,
EMBASE), all
searches should
be supplemented
No Yes Yes Yes Yes No
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
by
consulting cur-
rent contents, re-
views, textbooks,
specialised regis-
ters, or experts
in the particu-
lar field of study,
and by reviewing
the references in
the studies found
(E) Journals were
“hand-searched”
or “man-
ual searched” (i.
e. identi-
fying highly rele-
vant journals and
conducting
a manual, page-
by-page search of
their entire con-
tents looking for
potentially eligi-
ble studies)
No No No No No No
Score 3 4 4 4 4 3
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?
(A) The authors
should state that
they searched for
reports regard-
less of their pub-
lication type
*No *No No *No Yes *No
(B) The authors
should
state whether or
not they
excluded any re-
ports (from
the systematic re-
view), based on
their publication
status, language,
etc
Yes Yes Yes Yes Yes Yes
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
(C) “Non-En-
glish papers were
translated”
or readers suffi-
ciently trained in
foreign language
Yes No Yes Yes No No
(D) No language
restric-
tion or recogni-
tion of non-En-
glish articles
Yes Yes Yes Yes Yes Yes
Score 4 3 4 4 4 3
5. Was a list of studies (included and excluded) provided?
(A) Table/
list/figure of in-
cluded studies,
a reference list
does not suffice
Yes Yes Yes Yes Yes Yes
(B) Table/
list/figure of ex-
cluded studies,
either in the arti-
cle or in a supple-
mental source (i.
e. online)
. (Excluded stud-
ies refers to those
studies
seriously consid-
ered on the ba-
sis of title and/or
abstract, but re-
jected after read-
ing the body of
the text)
Yes Yes Yes Yes Yes Yes
(C) Author satis-
factorily/suffi-
ciently stated the
reason for ex-
clusion of the
seriously consid-
ered studies
Yes Yes Yes Yes Yes Yes
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
(D) Reader was
able to retrace
the included and
the excluded
studies anywhere
in the article bib-
liography, refer-
ence or supple-
mental source
Yes Yes Yes Yes Yes Yes
Score 4 4 4 4 4 4
6. Were the characteristics of the included studies provided?
(A) In an aggre-
gated form such
as a table, data
from the original
studies should be
provided on the
partic-
ipants, interven-
tions AND out-
comes
Yes Yes Yes Yes Yes Yes
(B) Provide the
ranges of rele-
vant characteris-
tics in the stud-
ies analysed (e.g.
age, race, sex, rel-
evant socioeco-
nomic data, dis-
ease status, dura-
tion, sever-
ity or other dis-
eases should be
reported)
Yes Yes Yes Yes Yes Yes
(C)
The information
provided appears
to be complete
and accurate (i.e.
there was a tol-
erable range of
subjectivity here.
Is the reader left
wondering? If so,
Yes Yes Yes Yes Yes Yes
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
state the needed
information and
the reasoning)
Score 4 4 4 4 4 4
7. Was the scientific quality of the included studies assessed and documented?
(A) ’A priori’
methods of as-
sessment should
be provided (e.g.
for effectiveness
studies if the au-
thor(s) chose to
include only ran-
domised,
double-
blind, placebo-
controlled stud-
ies, or allocation
concealment
as inclusion cri-
teria); for other
types of studies
alternative items
will be relevant
Yes Yes Yes Yes Yes Yes
(B) The
scientific quality
of the included
studies appeared
to be meaningful
Yes Yes Yes Yes Yes Yes
(C) Discussion/
recognition/
awareness of
level of evidence
Yes Yes Yes Yes Yes Yes
(D) Quality of
evidence should
be rated/ranked
based on char-
acterised instru-
ments. (Charac-
terised instru-
ment is a created
instrument that
ranks the level
No No No No No No
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
of evidence, e.g.
GRADE (Grad-
ing of Recom-
mendations As-
sessment, Devel-
opment and
Evaluation))
Score 3 3 3 3 3 3
8. Was the scientific quality of the included studies used appropriately in formulating conclusions?
(A)The results of
the methodolog-
ical rigor and
scientific quality
should be con-
sid-
ered in the anal-
ysis and the con-
clusions of the
review
Yes Yes Yes Yes Yes Yes
(B)The results of
the methodolog-
ical rigor and sci-
entific
quality were ex-
plicitly stated in
formulating rec-
ommendations
No No No No No Yes
(C) To have
conclusions inte-
grated/drives to-
wards a clinical
consensus state-
ment
Yes Yes Yes Yes Yes Yes
(D) This clinical
consensus state-
ment drives to-
wards revision or
confirmation of
clinical practice
guidelines
No No No Yes No No
Score 2 2 2 3 2 3
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
9. Were the methods used to combine the findings of studies appropriate?
(A) Statement of
criteria that were
used to decide
that
the studies anal-
ysed were simi-
lar enough to be
pooled?
Yes Yes No Yes Yes Yes
(B) For the
pooled results, a
test should be
done to ensure
the studies were
com-
binable, to assess
their homogene-
ity (i.e. Chi2 test
for homogeneity,
I2 statistic)
Yes Yes Yes Yes Yes NA
(C)
Is there a recog-
nition of hetero-
geneity or lack of
thereof
Yes Yes Yes Yes Yes Yes
(D) If hetero-
geneity exists a
“random-effects
model” should
be used or the ra-
tionale (i.e. clin-
ical appropriate-
ness) of combin-
ing should be
taken into con-
sideration (i.e. is
it sensi-
ble to combine?)
, or stated explic-
itly (or both)
Yes Yes Yes Yes Yes NA
(E) If
homogeneity ex-
ists, author
should state a ra-
Yes Yes NA NA Yes NA
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
tionale or a sta-
tistical test
Score 4 4 3 4 4 2
10. Was the likelihood of publication bias (a.k.a. “file drawer” effect) assessed?
(A) Recogni-
tion of publica-
tion bias or file-
drawer effect
Yes Yes Yes Yes Yes Yes
(B) An assess-
ment of publica-
tion bias should
include graphi-
cal aids (e.g. fun-
nel plot, other
available tests)
Yes Yes Yes Yes Yes No
(C) Statistical
tests (e.g. Egger
regression test)
Yes Yes Yes Yes Yes No
Score 4 4 4 4 4 2
11. Was the conflict of interest stated?
(A) Statement of
sources of sup-
port
Yes Yes Yes Yes Yes Yes
(B) No conflict
of interest.
This is subjective
and may require
some deduction
or searching
Yes Yes Yes Yes Yes Yes
(C) An aware-
ness/state-
ment of support
or conflict of in-
terest in the pri-
mary inclusion
studies
No No No No No No
Score 3 3 3 3 3 3
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Table 3. R-AMSTAR assessment of included systematic reviews (Continued)
Total score (n/
44)
39 39 39 41 40 35
CHD: coronary heart disease; HF: heart failure.
* Studies were screened independently by 2 review authors. Data were extracted by 1 review author and checked by a second review
author.
** While the authors did not explicitly state that they searched for reports regardless of publication type, it was clear from the included
studies or text (or both) that a search of grey literature was conducted.
Table 4. Risk of bias of included randomised controlled trials
Review short
title
(reference)
Exercise for
CHD
(Heran 2011)
Exercise for
HF
(Taylor
2014b)
Psychological
for CHD
(Whalley
2011)
Education for
CHD
(Brown 2011)
Home vs.
centre
(Taylor
2014a)
Uptake and
adherence
(Karmali
2014)
Total
Number of RCTs with low risk of bias (%)
Random se-
quence gen-
eration
8 (17) 10 (30) 7 (29) 9 (69) 4 (24) 9 (50) 47 (31)
Allocation
concealment
7 (15) 6 (18) 7 (29) 7 (54) 7 (41) 8 (44) 41 (27)
Groups bal-
anced at base-
line
a27 (57) 32 (97) a10 (42) 12 (92) 14 (82) ab9 (56) 103 (68)
Outcome
blinding
4 (9) 11 (33) 5 (21) 4 (31) 7 (41) 5 (28) 36 (24)
Selective
reporting
0 (0) 31 (94) 16 (67) 12 (92) 16 (94) 15 (83) 90 (59)
Loss to fol-
low-up <
20%
33 (70) 29 (88) 13 (54) 10 (77) 11 (65) 4 (22) 99 (65)
Intention-to-
treat analysis
a19 (40) 29 (88) 22 (92) 11 (85) 14 (82) ab7 (44) 101 (66)
Groups
received same
treatment
apart from
intervention*
a21 (45) 21 (64) a16 (67) 11 (85) 15 (88) ab15 (94) 100 (66)
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CHD: coronary heart disease; HF: heart failure; RCT: randomised controlled trial.
a Risk of bias was not reported within the review, but was assessed by the authors of this overview.
b Denominator = 16 as 2 studies were unavailable to us as they were unpublished degree dissertations.
Table 5. Exercise-based cardiac rehabilitation for coronary heart disease
Exercise-based cardiac rehabilitation for coronary heart disease
Patient or population: people with CHD
Settings:
Intervention: exercise-based CR
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
No of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
Control Exercise-based
CR
Total mortality
Follow-up: 6-12
months
Study population RR 0.82
(0.67 to 1.01)
6000
(19 studies)
⊕⊕©©
low1,2
-
65 per 1000 53 per 1000
(43 to 65)
53 per 1000
(43 to 65)
Moderate Moderate
- - -
Total mortality
Follow-up: 12-
120 months
Study population RR 0.87
(0.75 to 0.99)
5790
(16 studies)
⊕⊕⊕©
moderate1
-
126 per 1000 109 per 1000
(94 to 125)
109 per 1000
(94 to 125)
Moderate Moderate
- - -
Cardiovascular
mortality
Follow-up: 6-12
months
Study population RR 0.93
(0.71 to 1.21)
4130
(9 studies)
⊕⊕©©
low1,2
-
51 per 1000 48 per 1000
(36 to 62)
48 per 1000
(36 to 62)
Moderate Moderate
- - -
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Table 5. Exercise-based cardiac rehabilitation for coronary heart disease (Continued)
Cardiovascular
mortality
Follow-up: 12-
120 months
Study population RR 0.74
(0.63 to 0.87)
4757
(12 studies)
⊕⊕⊕©
moderate1
-
129 per 1000 96 per 1000
(81 to 112)
96 per 1000
(81 to 112)
Moderate Moderate
- - -
Hospitalisa-
tions
Follow-up: 6-12
months
Study population RR 0.69
(0.51 to 0.93)
463
(4 studies)
⊕⊕⊕©
moderate1
-
324 per 1000 224 per 1000
(165 to 302)
224 per 1000
(165 to 302)
Moderate Moderate
- - -
Hospitalisa-
tions
Follow-up: 12-
48 months
Study population RR 0.98
(0.87 to 1.11)
2009
(7 studies)
⊕⊕©©
low1,3
-
342 per 1000 335 per 1000
(297 to 379)
335 per 1000
(297 to 379)
Moderate Moderate
- - -
MI
Follow-up: 6-12
months
Study population RR 0.92
(0.7 to 1.22)
4216
(12 studies)
⊕©©©
very low1,2,4
-
45 per 1000 41 per 1000
(32 to 55)
41 per 1000
(32 to 55)
Moderate Moderate
- - -
MI
Follow-up: 12-
120 months
Study population RR 0.97
(0.82 to 1.15)
5682
(16 studies)
⊕⊕©©
low1,4
-
89 per 1000 87 per 1000
(73 to 103)
87 per 1000
(73 to 103)
Moderate Moderate
- - -
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Table 5. Exercise-based cardiac rehabilitation for coronary heart disease (Continued)
CABG
Follow-up: 6-12
months
Study population RR 0.91
(0.67 to 1.24)
2312
(14 studies)
⊕⊕©©
low1,2
-
67 per 1000 61 per 1000
(45 to 83)
61 per 1000
(45 to 83)
Moderate Moderate
- - -
CABG
Follow-up: 12-
120 months
Study population RR 0.93
(0.68 to 1.27)
2189
(9 studies)
⊕⊕©©
low1,2
-
69 per 1000 64 per 1000
(47 to 88)
64 per 1000
(47 to 88)
Moderate Moderate
- - -
PTCA
Follow-up: 6-12
months
Study population RR 1.02
(0.69 to 1.5)
1328
(7 studies)
⊕⊕©©
low1,2
-
69 per 1000 71 per 1000
(48 to 104)
71 per 1000
(48 to 104)
Moderate Moderate
- - -
PTCA
Follow-up: 12-
48 months
Study population RR 0.89
(0.66 to 1.19)
1322
(6 studies)
⊕⊕©©
low1,2
-
124 per 1000 110 per 1000
(82 to 147)
110 per 1000
(82 to 147)
Moderate Moderate
- - -
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CABG: coronary artery bypass graft;CHD: coronary heart disease;CI: confidence interval;CR: cardiac rehabilitation;MI:myocardial
infarction; PTCA: percutaneous transluminal coronary angioplasty; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
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Table 5. Exercise-based cardiac rehabilitation for coronary heart disease (Continued)
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment were poorly described; bias likely.
2 The 95% CIs include both no effect and appreciable benefit or harm (i.e. RR < 0.75 or > 1.25).
3 Moderate heterogeneity (I2 > 50%).
4 Funnel plots or Egger test (or both) suggest evidence of asymmetry
Table 6. Exercise-based cardiac rehabilitation for heart disease
Exercise-based cardiac rehabilitation for heart failure
Patient or population: people with HF
Settings:
Intervention: exercise-based CR
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
No of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
Control Exercise-based
CR
Total mortality
Follow-up: 6-12
months
Study population RR 0.93
(0.69 to 1.27)
1871
(25 studies)
⊕⊕©©
low1,2
-
75 per 1000 70 per 1000
(52 to 96)
70 per 1000
(52 to 96)
Moderate Moderate
- - -
Total mortality
Follow-up: 12-
120 months
Study population RR 0.88
(0.75 to 1.02)
2845
(6 studies)
⊕⊕©©
low1,2
-
196 per 1000 173 per 1000
(147 to 200)
173 per 1000
(147 to 200)
Moderate Moderate
- - -
Hospitalisa-
tions
Follow-up: 6-12
months
Study population RR 0.75
(0.62 to 0.92)
1328
(15 studies)
⊕⊕⊕©
moderate1
-
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Table 6. Exercise-based cardiac rehabilitation for heart disease (Continued)
227 per 1000 170 per 1000
(141 to 209)
170 per 1000
(141 to 209)
Moderate Moderate
- - -
Hospitalisa-
tions
Follow-up: 12-
74 months
Study population RR 0.92
(0.66 to 1.29)
2722
(5 studies)
⊕©©©
very low1,2,3
-
604 per 1000 556 per 1000
(399 to 779)
556 per 1000
(399 to 779)
Moderate Moderate
- - -
Hospi-
talisations (HF-
specific admis-
sions)
Follow-up: 12-
120 months
Study population RR 0.61
(0.46 to 0.8)
1036
(12 studies)
⊕⊕⊕©
moderate1,2
-
182 per 1000 111 per 1000
(84 to 145)
111 per 1000
(84 to 145)
Moderate Moderate
- - -
HRQoL
MLWHF score
Follow-up: 6-12
months
- The
meanHRQoL in
the intervention
groups was
5.8 lower
(9.21 to 2.44
lower)
- 1270
(13 studies)
⊕©©©
very low1,3,4
-
HRQoL
All HRQoL
measures
Follow-up: 12-
120 months
- The
meanHRQoL in
the intervention
groups was
0.46 lower
(0.66 to 0.26
lower)
- 3240
(13 studies)
⊕©©©
very low1,2,3,4
-
HRQoL
MLWHF
Follow-up: 6-
120 months
- The
meanHRQoL in
the intervention
groups was
9.49 lower
(17.48 to 1.5
lower)
- 329
(20 studies)
⊕©©©
very low1,2,3,4
-
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Table 6. Exercise-based cardiac rehabilitation for heart disease (Continued)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CI: confidence interval; CR: cardiac rehabilitation; HF: heart failure; HRQoL: health-related quality of life; MLWHF: Minnesota
Living with Heart Failure questionnaire; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment were poorly described; bias likely.
2 The 95% CIs include both no effect and appreciable benefit or harm (i.e. RR < 0.75 or > 1.25).
3 Moderate heterogeneity (I2 > 50%).
4 Funnel plots or Egger test (or both) suggest evidence of asymmetry
Table 7. Psychological-based interventions for coronary heart disease
Psychological-based interventions for coronary heart disease
Patient or population: people with CHD
Settings:
Intervention: psychological-based interventions
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
No of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
Control Psycholog-
ical-based inter-
ventions
Total mortality
Follow-up: 6-12
months
Study population RR 0.89
(0.75 to 1.05)
6852
(17 studies)
⊕⊕©©
low1,2
-
93 per 1000 83 per 1000
(70 to 98)
83 per 1000
(70 to 98)
Moderate Moderate
- - -
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Table 7. Psychological-based interventions for coronary heart disease (Continued)
Cardiovascular
mortality
Follow-up: 6-15
months
Study population RR 0.80
(0.64 to 1)
3893
(5 studies)
⊕⊕©©
low1,2
-
85 per 1000 68 per 1000
(55 to 85)
68 per 1000
(55 to 85)
Moderate Moderate
- - -
MI (non-fatal)
Follow-up: 6-15
months
Study population RR 0.87
(0.67 to 1.13)
7534
(12 studies)
⊕⊕©©
low1,2
-
83 per 1000 72 per 1000
(55 to 94)
72 per 1000
(55 to 94)
Moderate Moderate
Revascular-
isation (CABG
and PTCA com-
bined)
Follow-up: 6-15
months
Study population RR 0.95
(0.8 to 1.13)
6670
(12 studies)
⊕⊕⊕©
moderate1
-
121 per 1000 115 per 1000
(97 to 137)
115 per 1000
(97 to 137)
Moderate Moderate
- - -
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CABG: coronary artery bypass graft; CHD: coronary heart disease; CI: confidence interval; MI: myocardial infarction; PTCA:
percutaneous transluminal coronary angioplasty; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment were poorly described; bias likely.
2 The 95% CIs include both no effect and appreciable benefit or harm (i.e. RR < 0.75 or > 1.25)
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Table 8. Education-based interventions for coronary heart disease
Education-based interventions for coronary heart disease
Patient or population: people with CHD
Settings:
Intervention: education-based interventions
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
No of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
Control Edu-
cation-based in-
terventions
Total mortality
deaths
Follow-up: me-
dian 18 months
Study population RR 0.79
(0.55 to 1.13)
2330
(6 studies)
⊕⊕⊕©
moderate1
-
96 per 1000 76 per 1000
(53 to 108)
76 per 1000
(53 to 108)
Moderate Moderate
- - -
Hospitalisa-
tions
Study population RR 0.83
(0.65 to 1.07)
12,905
(4 studies)
⊕⊕⊕©
moderate1
-
64 per 1000 53 per 1000
(41 to 68)
53 per 1000
(41 to 68)
Moderate Moderate
- - -
MI Study population RR 0.63
(0.26 to 1.48)
209
(2 studies)
⊕©©©
very low2
-
118 per 1000 74 per 1000
(31 to 174)
74 per 1000
(31 to 174)
Moderate Moderate
- - -
CABG Study population RR 0.58
(0.19 to 1.71)
209
(2 studies)
⊕⊕©©
low2
-
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Table 8. Education-based interventions for coronary heart disease (Continued)
78 per 1000 45 per 1000
(15 to 134)
45 per 1000
(15 to 134)
Moderate Moderate
- - -
All-cause with-
drawal
Study population RR 1.03
(0.83 to 1.27)
2862
(8 studies)
⊕⊕⊕©
moderate1
-
181 per 1000 186 per 1000
(150 to 230)
186 per 1000
(150 to 230)
Moderate Moderate
- - -
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CABG: coronary artery bypass graft;CHD: coronary heart disease;CI: confidence interval;MI:myocardial infarction; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The 95% CIs include both no effect and appreciable benefit or harm (i.e. RR < 0.75 or > 1.25).
2 The 95% CIs include both no effect and substantial benefit or harm (i.e. RR < 0.50 or > 1.50)
Table 9. Home-based cardiac rehabilitation compared with centre-based cardiac rehabilitation for heart disease
Home-based cardiac rehabilitation compared with centre-based cardiac rehabilitation for heart disease
Patient or population: people with heart disease
Settings:
Intervention: home-based CR
Comparison: centre-based CR
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
No of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
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Table 9. Home-based cardiac rehabilitation compared with centre-based cardiac rehabilitation for heart disease (Continued)
Centre-based
CR
Home-based
CR
Total mortality
Follow-up: 3-12
months
Study population RR 0.79
(0.43 to 1.47)
1166
(7 studies)
⊕⊕©©
low1,2
-
27 per 1000 22 per 1000
(12 to 40)
22 per 1000
(12 to 40)
Moderate Moderate
- - -
All-cause with-
drawal
Follow-up: me-
dian 6 months
Study population RR 1.04
(1.01 to 1.07)
1984
(18 studies)
⊕⊕⊕©
moderate1
-
874 per 1000 909 per 1000
(883 to 936)
909 per 1000
(883 to 936)
Moderate Moderate
- - -
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CI: confidence interval; CR: cardiac rehabilitation; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment were poorly described; bias likely.
2 The 95% CIs include both no effect and appreciable benefit or harm (i.e. RR < 0.75 or > 1.25)
Table 10. Summary of outcome results across Cochrane systematic reviews
Review short ti-
tle
(reference)
Exercise for
CHD
(Heran 2011)
Exercise for HF
(Taylor 2014b)
Psychological
for CHD
(Whalley 2011)
Education for
CHD
(Brown 2011)
Home vs. centre
(Taylor 2014a)
Uptake and ad-
herence
(Karmali 2014)
Total mortality Follow-up < 12
months
19 RCTs (6000
participants),
Follow-up < 12
months
25 RCTs (1871
participants)
17 RCTs (6852
participants)
RR 0.89; 95%
CI 0.75 to 1.05
6 RCTs (2330
participants)
RR 0.79; 95%
CI 0.55 to 1.13
Follow-up < 12
months
7 RCTs (1166
participants)
3 RCTs (211
participants)
0/
3 RCTs reported
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Table 10. Summary of outcome results across Cochrane systematic reviews (Continued)
RR 0.82; 95%
CI 0.67 to 1.01
I2 = 0%
Follow-up > 12
months
16 RCTs (5790
participants)
RR 0.87; 95%
CI 0.75 to 0.99
I2 = 0%
RR 0.93; 95%
CI 0.697 to 1.27
I2 = 0%
Follow-up > 12
months
6 RCTs (2845
participants)
RR 0.88; 95%
CI 0.75 to 1.02
I2 = 34%
I2 = 2% I2 = 16% RR 0.79; 95%
CI 0.43 to 1.47
I2 = 0%
Follow-up > 12
months
1 RCT (525 par-
ticipants)
RR 1.99; 95%
CI 0.50 to 7.88
a significant dif-
ference between
intervention and
control groups
(no pooling of
data)
Cardiovascular
mortality
Follow-up < 12
months
9 RCTs (4130
participants)
RR 0.93; 95%
CI 0.71 to 1.21
I2 = 0.0%
Follow-up > 12
months
12 RCTs (4757)
RR 0.74; 95%
CI 0.63 to 0.87
I2 = 0%
“Studies did not
consistently report
deaths due
to heart failure or
sudden death”
5 RCTs (3893
participants)
RR 0.80; 95%
CI 0.6 to 1.00
I2 = 0.0%
NR NR NR
Hospitalisation Follow-up < 12
months
4 RCTs (463
participants)
RR 0.69; 95%
CI 0.51 to 0.93
I2 = 12%
Follow-up > 12
months
7 RCTs (2009
participants)
RR 0.98; 95%
CI 0.87 to 1.11
I2 = 56%
Follow-up < 12
months
15 RCTs (1328
participants)
RR 0.75; 95%
CI 0.62 to 0.92
I2 = 0%
Follow-up > 12
months
5 RCTs (2722
participants)
RR 0.92; 95%
CI 0.66 to 1.29
I2 = 63%
NR At end of fol-
low-up period
4 RCTs (12,905
participants)
RR 0.83; 95%
CI 0.65 to 1.07
I2 = 32%
1 RCT
No dif-
ference between
home-based and
centre-based CR
3 RCTs (num-
bers NR)
No significant
dif-
ference between
intervention and
control groups
(no pooling of
data)
HF-specific ad-
missions
NR Follow-up > 12
months
12 RCTs (1036
participants)
RR 0.61; 95%
CI 0.46 to 0.80
I2 = 34%
NR 1 RCT
Partic-
ipants in the in-
tervention group
had 41% fewer
(P value = 0.05)
and 61% fewer
heart-related in-
patient days
NR NR
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Table 10. Summary of outcome results across Cochrane systematic reviews (Continued)
(P value = 0.02)
than in the con-
trol group
Events
MI
Fatal or non-fa-
tal(or both) MI
Follow-up < 12
months
12 RCTs (4216
participants)
RR 0.92; 95%
CI 0.70 to 1.22
I2 = 19%
Follow-up > 12
months
16 RCTs (5682
participants)
RR 0.97; 95%
CI 0.82 to 1.15
I2 = 25%
NR Non-fatal MI
12 RCTs (7534
participants)
RR 0.87; 95%
CI 0.67 to 1.13
I2 = 31%
MI at the end
of the follow-up
period
2 RCTs (209
participants)
RR 0.63; 95%
CI 0.26 to 1.48
I2 = 0%
2 RCTs
No dif-
ference between
home-based and
centre-based CR
(no pooling of
data performed)
CHD event
rates
3 RCTs (414
participants)
2/3 RCTs
reported no dif-
ference between
intervention and
control groups
1 RCT (228 par-
ticipants)
RR 1.66, P value
< 0.01
CABG Follow-up < 12
months
14 RCTs (2312
participants)
RR 0.91; 95%
CI 0.67 to 1.24
I2 = 0%
Follow-up > 12
months
9 RCTs (2189
participants)
RR 0.93; 95%
CI 0.68 to 1.27
I2 = 0%
NR Revascular-
isation (CABG
and PTCA com-
bined)
12 RCTs (6670
participants)
RR 0.95; 95%
CI 0.80 to 1.13
I2 = 13%
At end of fol-
low-up period
2 RCTs (209
participants)
RR 0.58; 95%
CI 0.19 to 1.71
I2 = 0%
Not reported by
RCTs
-
PTCA Follow-up < 12
months
7 RCTs (1328
participants)
RR 1.02; 95%
CI 0.69 to 1.50
I2 = 12%
Follow-up > 12
months
6 RCTs (1322
participants)
RR 0.89; 95%
CI 0.66 to 1.19
I2 = 20%
NR Revascular-
isation (CABG
and PTCA com-
bined)
12 RCTs (6670
participants)
RR 0.95; 95%
CI 0.80 to 1.13
I2 = 13%
Not reported by
RCTs
Not reported by
RCTs
-
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Table 10. Summary of outcome results across Cochrane systematic reviews (Continued)
HRQoL 10 RCTs
7/10 RCTs re-
ported evidence
of a significantly
higher level of
HRQoL with in-
tervention at fol-
low-up
20 RCTs
Follow-up < 12
months
13 RCTs (1270
participants)
MLWHF score:
MD -5.8; 95%
CI -9.2 to -2.4
I2 = 70%
Follow up > 12
months
3 RCTs (329
participants)
MD -9.5; 95%
CI -17.54 to -1.
5
I2 = 73%
All HRQoL
measures
pooled
20 RCTs (3240
participants)
SMD -0.5; 95%
CI -0.7 to -0.3
I2 = 79%
7 RCTs
1/7 RCTs re-
ported evidence
of a significantly
higher level of
HRQoL with in-
tervention at fol-
low-up
Across 11 RCTs,
81 HRQoL out-
come scores/sub-
scores reported:
14/81 in favour
of interven-
tion compared to
control
67/81 no signifi-
cant dif-
ference between
intervention and
control
5/11 RCTs re-
ported evidence
of a significantly
higher level
of some HRQoL
domains with in-
tervention at fol-
low-up
No con-
sistent difference
in HRQoL total
or domain score
at follow-up be-
tween interven-
tion and control
10 RCTs
8/10 RCTs re-
ported
improvements in
HRQoL at fol-
low-up
with both home-
based and cen-
tre-
based CR com-
pared with base-
line
No strong evi-
dence of differ-
ence in
overall HRQoL
outcomes or do-
main score at fol-
low up between
home-based and
centre-based CR
2 RCTs
1/
2 RCTs reported
improvement in
HRQoL with in-
tervention (not
significant)
1/2 RCTs re-
ported improve-
ment in both
groups but no
significant dif-
ference between
intervention and
control
Economics
Costs
Cost-
effectiveness
Costs
3 RCTs
2/3 stud-
ies reported total
healthcare costs
were not statisti-
cally signif-
icantly different
between groups
Cost-
effectiveness
1 RCT
Authors con-
cluded that re-
habilitation was
an efficient use
of healthcare re-
sources and may
be economically
justified
3 RCTs
2 studies under-
took a cost effec-
tiveness analysis
and 1 reported
costs
There was no
evidence of sig-
nificantly differ-
ent costs or out-
comes
NR 5 RCTs reported
healthcare utili-
sation costs
2/5 RCTs
reported an over-
all mean net sav-
ing of USD965
per participant at
6months follow-
up and
USD1420
per participant at
24 months fol-
low-up
1/
5 RCTs reported
an increase in
mean net costs of
USD52 per par-
3/
4 RCTs reported
healthcare costs
associated with
CR were lower
for the home-
based than cen-
tre-based
programmes
1/
4 RCTs reported
that home-based
CR was more
costly than cen-
tre-basedCR but
costs would be
the same if par-
ticipant
travel costs and
NR
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Table 10. Summary of outcome results across Cochrane systematic reviews (Continued)
ticipant
2/
5 RCTs reported
no difference be-
tween groups
No RCTs
reported cost-ef-
fectiveness
travel time were
included
8
studies reported
different aspects
of consumption
of healthcare re-
sources
No sig-
nificant between
group differ-
ences were seen
All-cause with-
drawal /
drop-out at fol-
low-up
NR NR NR At follow-up
8 RCTs (2862
participants)
RR 1.03; 95%
CI 0.83 to 1.27
I2 = 34%
At follow-up
18 (1894 partic-
ipants)
RR 1.04; 95%
CI 1.00 to 1.08
I2 = 44%
NR
Uptake NR NR NR NR NR 10 RCTs (1338
participants)
8/10 RCTs
reported uptake
was significantly
higher in inter-
vention group
Adherence NR NR NR NR 14 RCTs
*3/14 RCTs re-
ported adher-
ence was signifi-
cantly higher in
home-based CR
8 RCTs (1150
participants)
3/
8 RCTs reported
adherence
was significantly
higher in inter-
vention group
CABG: coronary artery bypass graft; CHD: coronary heart disease; CR: cardiac rehabilitation; HF: heart failure;HRQoL: health-related
quality of life; MD: mean difference; MI: myocardial infarction; MLWHF: Minnesota Living with Heart Failure questionnaire;
NR: not reported; PTCA: percutaneous transluminal coronary angioplasty; RCT: randomised controlled trial; RR: risk ratio; SMD:
standardised mean difference.
* As reported in the ’Summary of findings’ table. Effects of interventions section states 4/14.
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A P P E N D I C E S
Appendix 1. Search strategy
The Cochrane Library
#1 cardiac near/4 rehab*
#2 cardiac near/4 exercise*
#1 OR #2
Appendix 2. Excluded systematic reviews
Author Title Reason for exclusion from overview
Hulzebos 2012 Preoperative physical therapy for elective cardiac surgery
patients
Only 1/8 included randomised controlled trials com-
pared cardiorespiratory exercise training with a non-ex-
ercise control
Appendix 3. Protocols identified
Author Title
Devi 2011 Internet-based interventions for the secondary prevention of coronary heart disease
Euler 2013 Interventions to support return-to-work for patients with coronary heart disease
*Mechta-Nielsen 2014 Exercise-based cardiac rehabilitation for adult patients with ICD
Risom 2014 Exercise-based cardiac rehabilitation for adults with atrial fibrillation
Sibilitz 2013 Exercise-based cardiac rehabilitation for adults after heart valve surgery
*We are aware of this proposed title through personal communication with the authors.
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